SABCS 2021: Study Reveals Difficulties With Adherence to Ribociclib Therapy in the Adjuvant Setting for Breast Cancer
Adherence and tolerability did not differ with intermittent or continuous dosing regimens
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.